GNLX Stock Analysis: Buy, Sell, or Hold?
GNLX - Genelux Corporation Common Stock
$3.11
0.28 (9.89%)
▲
5d:
+13.5%
30d:
+21.48%
90d:
+30.13%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When GNLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: GNLX is 10.7% above its trading range ($2.81). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: GNLX is 10.7% above its trading range ($2.81). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GNLX is currently trading at $3.11, which is considered extended relative to its 30-day fair value range of $2.49 to $2.81.
Technical Outlook: Technically, GNLX is in a downtrend. The price is approaching resistance at $3.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: GNLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.50 (+462.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GNLX is in a downtrend. The price is approaching resistance at $3.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: GNLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.50 (+462.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.49 -
$2.81
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price significantly overextended (+10.7% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.9%)
- BULLISH: Trading 462.7% below Wall St target ($17.50)
- WARNING: Recommendation downgraded due to 10.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$2.49 -
$2.81
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.49
(15.7%)
Support & Resistance Levels
Support Level
$2.46
Resistance Level
$3.20
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.78
Wall Street Target
$17.50
(+462.7%)
Revenue Growth (YoY)
-95.3%
Share & Embed Analysis
Last updated: May 08, 2026 6:19 PM ET
Data refreshes hourly during market hours. Next update: 7:19 PM
Data refreshes hourly during market hours. Next update: 7:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
John Thomas
SELL
10000 shares
2026-03-02
Ralph Smalling
SELL
165 shares
2025-12-05
John Thomas
SELL
10000 shares
2025-12-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$100 | 69 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 58 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 56 HOLD |
